ClinicalTrials.Veeva

Menu

Graphene-Reinforced CAD/CAM Restorations for MIH-Affected Molars in Adolescents: A Prospective Clinical Study

U

Universitat Internacional de Catalunya

Status

Not yet enrolling

Conditions

Enamel Mineralization Disorders
Tooth Demineralization
Tooth Eruption Disorder
Tooth Sensitivity
Tooth Sensitivity After Composite Restorations
Indirect Restoration

Treatments

Device: Graphene-reinforced CAD/CAM polymer (G-CAM®)

Study type

Interventional

Funder types

Other

Identifiers

NCT07329244
64/2025

Details and patient eligibility

About

This study evaluates the clinical performance, marginal integrity, surface wear, color stability, and postoperative sensitivity of graphene-reinforced CAD/CAM indirect restorations (inlays, onlays, overlays) in molars affected by moderate to severe Molar-Incisor Hypomineralization (MIH) in adolescents. A total of 30 patients aged 10-16 years will receive minimally invasive indirect restorations fabricated from a nano-reinforced graphene polymer (G-CAM®). Clinical outcomes will be assessed using FDI criteria, VAS sensitivity scores, patient satisfaction, and digital 3D scans over a 12-month follow-up. The study aims to determine clinical acceptability and safety compared with historical outcomes reported for composite and lithium-disilicate indirect restorations.

Full description

This is a prospective, single-arm, monocentric clinical trial designed to assess the functional performance, marginal adaptation, wear behavior, postoperative sensitivity, and structural preservation of graphene-reinforced CAD/CAM restorations placed on MIH-affected molars in adolescents aged 10-16 years. MIH lesions present compromised enamel quality with increased porosity, susceptibility to post-eruptive breakdown, and frequent hypersensitivity, making conventional restorative approaches less predictable.

Minimally invasive preparations will be performed followed by adhesive placement of graphene-reinforced CAD/CAM indirect restorations fabricated through a fully digital workflow (intraoral scanning, CAD design, CAM milling). Evaluations will be performed at baseline, 48 h, 1, 3, 6, and 12 months. Primary variables include global and domain-specific FDI clinical scores (marginal integrity, surface roughness, color stability, fractures/chipping, proximal contact, occlusion/function, soft tissue response) and postoperative sensitivity measured using a Visual Analog Scale (VAS). Secondary outcomes include patient satisfaction, tooth vitality, digital volumetric analysis of structural preservation, survival of restorations, and efficiency of the digital workflow.

Enrollment

30 estimated patients

Sex

All

Ages

10 to 16 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adolescents aged 10-16 years.
  • Permanent molars with moderate or severe MIH (EAPD criteria).
  • Vital and restorable teeth.
  • Ability to attend follow-up visits.
  • Informed consent from guardian + assent from the minor.

Exclusion criteria

  • Fluorosis, amelogenesis imperfecta, or other enamel defects.

  • Severe bruxism not controlled.

  • Active extensive caries or irreversible pulpitis.

  • Systemic conditions affecting enamel or healing.

  • Hypersensitivity/allergy to materials/adhesives.

  • Use of analgesics/AINEs <24 h before baseline VAS.

    • Orthodontic bands on the study molar.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

Graphene-Reinforced CAD/CAM Indirect Restoration
Experimental group
Description:
Minimally invasive preparation, composite base build-up when indicated, adhesive protocol with total-etch technique, CAD/CAM fabrication using graphene-reinforced polymer (G-CAM®), adhesive cementation under rubber dam isolation, finishing and polishing, and follow-up at 1 week, 3, 6, and 12 months.
Treatment:
Device: Graphene-reinforced CAD/CAM polymer (G-CAM®)

Trial documents
2

Trial contacts and locations

1

Loading...

Central trial contact

Luis Carlos Garza Garza

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems